Question to the Department for International Development:
To ask Her Majesty’s Government, further to the Written Answer by Baroness Northover on 21 October (HL2052), what proportion of spending on HIV, tuberculosis and malaria can be qualified as supporting research and development for new drugs, diagnostics and vaccines.
The estimated proportion of spend in the 2012/13 financial year, which is the most recent year for which we have figures, is:
Research as a % of bilateral plus Global Fund to Fight AIDS, TB and Malaria spend | |
Malaria | 8% |
TB | 4% |
HIV | 3% |